Taking all these together, our results demonstrate a strong positive association between EP300 mutations, overexpression and stemness/NK marker XCL1 related signatures, suggesting that EP300 may have a role promoting tumours to become a more aggressive subtype in ESCC. The gene discussed is XCL1; the disease is esophageal squamous cell carcinoma.